Reckitt Benckiser could be another angel on this too. Dr Hammond worked for them prior to joining OBJ as the partnering manager.
Looking on their R&D site, there are a few areas of interest to them that could be involving OBJ technology. They are also a multi-national FMCG
Research of interest to them includes,
Skin/Hair Systems
Micro/Nanoencapsulation for delivery of skin actives
Targeted skin delivery systems
Dermal pain reduction systems
Dermal adhesives
Skin evaluation methods
Skincare devices
Health Care
Immune system boosting
Active absorption enhancement technologies (systemic and topical)
Gastrointestinal treatments
Cold & Flu treatments
Topical and Systemic analgesics (Ibuprofen and Paracetamol)
Fast acting/fast dissolving formulations
Novel pharmaceutical dosage formats
Antiviral technologies
Controlled active release technologies especially for liquids
Mucal adhesives
- Forums
- ASX - By Stock
- WFL
- shareholder update
shareholder update, page-99
-
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable